标题
The pathogenicity of Th17 cells in autoimmune diseases
作者
关键词
-
出版物
Seminars in Immunopathology
Volume 41, Issue 3, Pages 283-297
出版商
Springer Science and Business Media LLC
发表日期
2019-04-17
DOI
10.1007/s00281-019-00733-8
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Satb1 regulates the effector program of encephalitogenic tissue Th17 cells in chronic inflammation
- (2019) Keiko Yasuda et al. Nature Communications
- Secukinumab improves active psoriatic arthritis symptoms and inhibits radiographic progression: primary results from the randomised, double-blind, phase III FUTURE 5 study
- (2018) Philip Mease et al. ANNALS OF THE RHEUMATIC DISEASES
- Autoimmune Th17 Cells Induced Synovial Stromal and Innate Lymphoid Cell Secretion of the Cytokine GM-CSF to Initiate and Augment Autoimmune Arthritis
- (2018) Keiji Hirota et al. IMMUNITY
- Secukinumab after anti-tumour necrosis factor-α therapy: a phase III study in active rheumatoid arthritis
- (2018) E Dokoupilová et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- Metabolic heterogeneity underlies reciprocal fates of TH17 cell stemness and plasticity
- (2018) Peer W. F. Karmaus et al. NATURE
- PTEN drives Th17 cell differentiation by preventing IL-2 production
- (2017) Hyeong Su Kim et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Ex-Th17 (Nonclassical Th1) Cells Are Functionally Distinct from Classical Th1 and Th17 Cells and Are Not Constrained by Regulatory T Cells
- (2017) Sharee A. Basdeo et al. JOURNAL OF IMMUNOLOGY
- JunB promotes Th17 cell identity and restrains alternative CD4+ T-cell programs during inflammation
- (2017) Tiffany M. Carr et al. Nature Communications
- JunB is essential for IL-23-dependent pathogenicity of Th17 cells
- (2017) Zafrul Hasan et al. Nature Communications
- A Randomized Phase IIb Study of Mavrilimumab and Golimumab in Rheumatoid Arthritis
- (2017) Michael E. Weinblatt et al. Arthritis & Rheumatology
- Secukinumab in Active Rheumatoid Arthritis: A Phase III Randomized, Double-Blind, Active Comparator- and Placebo-Controlled Study
- (2017) Francisco J. Blanco et al. Arthritis & Rheumatology
- Recent Advances in Defining the Genetic Basis of Rheumatoid Arthritis
- (2016) Chikashi Terao et al. Annual Review of Genomics and Human Genetics
- The Role of the Intestinal Microbiome in Type 1 Diabetes Pathogenesis
- (2016) James C. Needell et al. Current Diabetes Reports
- The MicroRNA-183-96-182 Cluster Promotes T Helper 17 Cell Pathogenicity by Negatively Regulating Transcription Factor Foxo1 Expression
- (2016) Kenji Ichiyama et al. IMMUNITY
- Interleukin-23-Induced Transcription Factor Blimp-1 Promotes Pathogenicity of T Helper 17 Cells
- (2016) Renu Jain et al. IMMUNITY
- IL-1–induced Bhlhe40 identifies pathogenic T helper cells in a model of autoimmune neuroinflammation
- (2016) Chih-Chung Lin et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Protein C receptor (PROCR) is a negative regulator of Th17 pathogenicity
- (2016) Yasuhiro Kishi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Rheumatoid arthritis
- (2016) Josef S Smolen et al. LANCET
- Update on the genetic architecture of rheumatoid arthritis
- (2016) Kwangwoo Kim et al. Nature Reviews Rheumatology
- Restoring oxidant signaling suppresses proarthritogenic T cell effector functions in rheumatoid arthritis
- (2016) Zhen Yang et al. Science Translational Medicine
- RBPJ Controls Development of Pathogenic Th17 Cells by Regulating IL-23 Receptor Expression
- (2016) Gerd Meyer zu Horste et al. Cell Reports
- Interleukin-17A expression in human synovial mast cells in rheumatoid arthritis and osteoarthritis
- (2016) Jun-ichiro Kan et al. ALLERGOLOGY INTERNATIONAL
- Dysbiosis Contributes to Arthritis Development via Activation of Autoreactive T Cells in the Intestine
- (2016) Yuichi Maeda et al. Arthritis & Rheumatology
- Suppression of Inflammatory Arthritis by Human Gut-Derived Prevotella histicola in Humanized Mice
- (2016) Eric V. Marietta et al. Arthritis & Rheumatology
- Single-Cell Genomics Unveils Critical Regulators of Th17 Cell Pathogenicity
- (2015) Jellert T. Gaublomme et al. CELL
- CD5L/AIM Regulates Lipid Biosynthesis and Restrains Th17 Cell Pathogenicity
- (2015) Chao Wang et al. CELL
- The Cytokine GM-CSF Drives the Inflammatory Signature of CCR2+ Monocytes and Licenses Autoimmunity
- (2015) Andrew L. Croxford et al. IMMUNITY
- Expression of GM-CSF in T Cells Is Increased in Multiple Sclerosis and Suppressed by IFN-β Therapy
- (2015) Javad Rasouli et al. JOURNAL OF IMMUNOLOGY
- Safety and Efficacy of Open-label Subcutaneous Ixekizumab Treatment for 48 Weeks in a Phase II Study in Biologic-naive and TNF-IR Patients with Rheumatoid Arthritis
- (2015) Mark C. Genovese et al. JOURNAL OF RHEUMATOLOGY
- Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2015) Iain B McInnes et al. LANCET
- IL-1 signaling modulates activation of STAT transcription factors to antagonize retinoic acid signaling and control the TH17 cell–iTreg cell balance
- (2015) Rajatava Basu et al. NATURE IMMUNOLOGY
- The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment
- (2015) Xuan Zhang et al. NATURE MEDICINE
- Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis, with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters
- (2015) Sachiko Miyake et al. PLoS One
- MOR103, a human monoclonal antibody to granulocyte–macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial
- (2014) Frank Behrens et al. ANNALS OF THE RHEUMATIC DISEASES
- One-year Efficacy and Safety Results of Secukinumab in Patients With Rheumatoid Arthritis: Phase II, Dose-finding, Double-blind, Randomized, Placebo-controlled Study
- (2014) M. C. Genovese et al. JOURNAL OF RHEUMATOLOGY
- A 52-week, open-label study of the efficacy and safety of ixekizumab, an anti-interleukin-17A monoclonal antibody, in patients with chronic plaque psoriasis
- (2014) Kenneth B. Gordon et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials
- (2014) Richard G. Langley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Detection of T cell responses to a ubiquitous cellular protein in autoimmune disease
- (2014) Y. Ito et al. SCIENCE
- A Phase II Randomized Study of Subcutaneous Ixekizumab, an Anti-Interleukin-17 Monoclonal Antibody, in Rheumatoid Arthritis Patients Who Were Naive to Biologic Agents or Had an Inadequate Response to Tumor Necrosis Factor Inhibitors
- (2014) Mark C. Genovese et al. Arthritis & Rheumatology
- Brief Report: T Cell Expression of Granulocyte-Macrophage Colony-Stimulating Factor in Juvenile Arthritis Is Contingent Upon Th17 Plasticity
- (2014) Christopher Piper et al. Arthritis & Rheumatology
- Phosphofructokinase deficiency impairs ATP generation, autophagy, and redox balance in rheumatoid arthritis T cells
- (2013) Zhen Yang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- CD28-inducible transcription factor DEC1 is required for efficient autoreactive CD4+T cell response
- (2013) Marc Martínez-Llordella et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Genetics of rheumatoid arthritis contributes to biology and drug discovery
- (2013) Yukinori Okada et al. NATURE
- Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1
- (2013) Chuan Wu et al. NATURE
- Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells
- (2013) Markus Kleinewietfeld et al. NATURE
- Plasticity of TH17 cells in Peyer's patches is responsible for the induction of T cell–dependent IgA responses
- (2013) Keiji Hirota et al. NATURE IMMUNOLOGY
- Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis
- (2013) Jose U Scher et al. eLife
- Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled study
- (2012) Mark C Genovese et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritis
- (2012) Gerd R Burmester et al. ANNALS OF THE RHEUMATIC DISEASES
- Increased levels of IL-23 and osteopontin in serum and cerebrospinal fluid of multiple sclerosis patients
- (2012) Shi-Rong Wen et al. JOURNAL OF NEUROIMMUNOLOGY
- High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis
- (2012) Steve Eyre et al. NATURE GENETICS
- Aiolos promotes TH17 differentiation by directly silencing Il2 expression
- (2012) Francisco J Quintana et al. NATURE IMMUNOLOGY
- Induction and molecular signature of pathogenic TH17 cells
- (2012) Youjin Lee et al. NATURE IMMUNOLOGY
- Evidence of the transient nature of the Th17 phenotype of CD4+CD161+ T cells in the synovial fluid of patients with juvenile idiopathic arthritis
- (2011) Lorenzo Cosmi et al. ARTHRITIS AND RHEUMATISM
- Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1
- (2011) Eric V. Dang et al. CELL
- HIF1α–dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Tregcells
- (2011) Lewis Z. Shi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Fate mapping of IL-17-producing T cells in inflammatory responses
- (2011) Keiji Hirota et al. NATURE IMMUNOLOGY
- RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation
- (2011) Laura Codarri et al. NATURE IMMUNOLOGY
- The encephalitogenicity of TH17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF
- (2011) Mohamed El-Behi et al. NATURE IMMUNOLOGY
- Analysis of SF and plasma cytokines provides insights into the mechanisms of inflammatory arthritis and may predict response to therapy
- (2011) H. L. Wright et al. RHEUMATOLOGY
- Th17 cells, but not Th1 cells, from patients with early rheumatoid arthritis are potent inducers of matrix metalloproteinases and proinflammatory cytokines upon synovial fibroblast interaction, including autocrine interleukin-17A production
- (2010) J. P. van Hamburg et al. ARTHRITIS AND RHEUMATISM
- Role of Th17 cells in human autoimmune arthritis
- (2010) Jan Leipe et al. ARTHRITIS AND RHEUMATISM
- Up-regulation of cytokines and chemokines predates the onset of rheumatoid arthritis
- (2010) Heidi Kokkonen et al. ARTHRITIS AND RHEUMATISM
- Th17 and Regulatory T Cells in Mediating and Restraining Inflammation
- (2010) Dan R. Littman et al. CELL
- Gut-Residing Segmented Filamentous Bacteria Drive Autoimmune Arthritis via T Helper 17 Cells
- (2010) Hsin-Jung Wu et al. IMMUNITY
- Complement drives Th17 cell differentiation and triggers autoimmune arthritis
- (2010) Motomu Hashimoto et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Cutting Edge: Mast Cells Express IL-17A in Rheumatoid Arthritis Synovium
- (2010) A. J. Hueber et al. JOURNAL OF IMMUNOLOGY
- Graded Attenuation of TCR Signaling Elicits Distinct Autoimmune Diseases by Altering Thymic T Cell Selection and Regulatory T Cell Function
- (2010) S. Tanaka et al. JOURNAL OF IMMUNOLOGY
- Generation of pathogenic TH17 cells in the absence of TGF-β signalling
- (2010) Kamran Ghoreschi et al. NATURE
- A regulatory variant in CCR6 is associated with rheumatoid arthritis susceptibility
- (2010) Yuta Kochi et al. NATURE GENETICS
- Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci
- (2010) Eli A Stahl et al. NATURE GENETICS
- Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment
- (2010) K. Nistala et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Gamma/delta T cells are the predominant source of interleukin-17 in affected joints in collagen-induced arthritis, but not in rheumatoid arthritis
- (2009) Yoshinaga Ito et al. ARTHRITIS AND RHEUMATISM
- Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria
- (2009) Ivaylo I. Ivanov et al. CELL
- Critical Regulation of Early Th17 Cell Differentiation by Interleukin-1 Signaling
- (2009) Yeonseok Chung et al. IMMUNITY
- The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17–producing effector T helper cells in vivo
- (2009) Mandy J McGeachy et al. NATURE IMMUNOLOGY
- Increased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondylarthritides
- (2008) Camilla Jandus et al. ARTHRITIS AND RHEUMATISM
- Crucial role of the interleukin-6/interleukin-17 cytokine axis in the induction of arthritis by glucose-6-phosphate isomerase
- (2008) Keiichi Iwanami et al. ARTHRITIS AND RHEUMATISM
- T Helper 17 Lineage Differentiation Is Programmed by Orphan Nuclear Receptors RORα and RORγ
- (2008) Xuexian O. Yang et al. IMMUNITY
- GM-CSF mediates autoimmunity by enhancing IL-6–dependent Th17 cell development and survival
- (2008) Ivo Sonderegger et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins
- (2008) Marc Veldhoen et al. NATURE
- Control of Treg and TH17 cell differentiation by the aryl hydrocarbon receptor
- (2008) Francisco J. Quintana et al. NATURE
- Impaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome
- (2008) Joshua D. Milner et al. NATURE
- A critical function for transforming growth factor-β, interleukin 23 and proinflammatory cytokines in driving and modulating human TH-17 responses
- (2008) Elisabetta Volpe et al. NATURE IMMUNOLOGY
- The differentiation of human TH-17 cells requires transforming growth factor-β and induction of the nuclear receptor RORγt
- (2008) Nicolas Manel et al. NATURE IMMUNOLOGY
- TH-17 cells in rheumatoid arthritis
- (2008) Shiva Shahrara et al. ARTHRITIS RESEARCH & THERAPY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now